Balanced news tone
News Sentiment
LNTH sentiment intelligence
Lantheus Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-3.9% over one week, +1.1% over four weeks, trend active, and materially above fair value.
Lantheus Holdings (LNTH) Could Be 2% Undervalued Following Its Alzheimer Imaging Narrative
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Lantheus Holdings Inc (LNTH) Shareholder Structure: Major Shareholders & Institutional Holdings
This article provides an overview of the shareholder structure of Lantheus Holdings Inc (LNTH), detailing its major shareholders and institutional holdings. It lists the top institutional investors, including BlackRock, Janus Henderson Investors, and Farallon Capital Management,
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 18:10
- Source
- TradingKey
Lantheus (LNTH) Proxy filing Summary
Lantheus (LNTH) recently filed a proxy statement detailing its upcoming annual meeting on April 30, 2026. Key items for shareholder vote include the election of four Class II directors, advisory votes on executive compensation, and a proposal to declassify the Board of Directors.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 14:10
- Source
- Quartr
Lantheus Holdings stock hits 52-week high at 104.05 USD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Investing.com
Assessing Lantheus Holdings (LNTH) Valuation After Strong Multi Month Share Price Gains
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Market source
Lantheus (LNTH) CEO Heino reports 1,227-share tax withholding and updated holdings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Stock Titan
Radiopharma firm Lantheus to speak at Goldman Sachs health event
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Stock Titan
Lantheus ASCO Data To Test Radiopharma Pipeline And Valuation Gap Narrative
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- simplywall.st
Is It Too Late To Consider Lantheus Holdings (LNTH) After Its Strong Share Price Run?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 24 May 2026 07:00
- Source
- simplywall.st
How The Story On Lantheus Holdings (LNTH) Is Shifting With PYLARIFY And Pipeline Expectations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- Market source
Lantheus (LNTH) Considers Sale Following Curium Acquisition Prop
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 May 2026 07:00
- Source
- GuruFocus
Lantheus weighs potential $7 billion sale after Curium's offer, Bloomberg News reports
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- Reuters
We Think You Should Be Aware Of Some Concerning Factors In Lantheus Holdings' (NASDAQ:LNTH) Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- simplywall.st
Lantheus Holdings (LNTH) Valuation Check After Q1 Earnings Beat And FDA Approval Catalysts
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- Market source
Here is Why Lantheus Holdings Inc (LNTH) Is Among the Best Medical AI Stocks to Invest In
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Apr 2026 07:00
- Source
- Market source
Lantheus Says FDA Pushed Deadline For Reviewing Its Tumor Diagnostic Kit Application
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Mar 2026 07:00
- Source
- Stocktwits
FDA extends review of Lantheus’ neuroendocrine tumor drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Mar 2026 07:00
- Source
- Investing.com
Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Stock Is Going Strong: Is the Market Following Fundamentals?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Feb 2026 08:00
- Source
- Market source
Why Lantheus (LNTH) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Dec 2025 08:00
- Source
- Market source
LNTH Stock Price and Chart — NASDAQ:LNTH
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jul 2025 07:00
- Source
- TradingView